Biorem Reports Record Quarterly Revenues and Earnings, - $14.9 Million of Revenues in the Quarter and Quarterly EPS of $0.14

In This Article:

GUELPH, ON, Nov. 6, 2024 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2024. BIOREM's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

FINANCIAL HIGHLIGHTS:

 in Canadian dollars, '000's except earnings per share



Three-months ended

Nine-months ended


September 30

September 30


2024

2023

2024

2023






Revenue

14,886

5,509

28,104

12,959

Gross profit

5,021

1,544

8,458

2,615

Operating expenses

1,992

806

4,401

2,630

Ebitda*

3,138

787

4,391

170

Net earnings (loss)

2,192

503

2,873

(147)

EPS - basic

0.14

0.03

0.18

(0.01)

EPS - fully diluted

0.12

0.03

0.16

(0.01)

* Earnings before interest, taxes and amortizaton, a non IFRS financial measure

BIOREM reported record quarterly revenues for the third quarter of $14.9 million, an increase of 103% over the previous quarter and 170% higher than the $5.5 million of revenues reported in the same quarter in 2023. Year to date revenues totalled $28.1 million, a 117% increase over the $13 million reported for the first nine months of 2023. The increase in revenues for the first nine months of 2024 compared to the prior year is largely attributable to the increase in order bookings and continuing delivery of projects from the Company's large order backlog.

During the quarter the Company booked $6.6 million in new orders resulting in an order backlog of $48.4 million on September 30, 2024. This compares to an order backlog of $57 million on June 30, 2024 and $54.5 million as of September 30, 2023.

The Company expects order bookings to continue to grow as and delivery of projects from the order backlog continues generating strong revenue and earnings growth over the next 12 months.

"In the third quarter, delays related to industry-wide issues with construction projects eased somewhat, allowing BIOREM to catch up on orders in the Company's backlog," said Derek S. Webb, President and CEO. "Even as project deliveries accelerated, BIOREM's sales funnel, outstanding bids and order backlog remain robust with no signs of softening over the near- to medium-term."

"Population growth and the need for significant increases in housing construction throughout North America is driving demand for municipal and industrial infrastructure projects that require air emission abatement systems. BIOREM's experience and performance in delivering both large and small successful air emission abatement projects makes them uniquely positioned to benefit over the long term from this growth cycle".